文献速递生殖医学

使用促性腺激素释放激素激动剂扳机时极高雌二醇浓度ART周期的治疗安全性

Treatment safety of ART cycles with extremely high oestradiol concentrations using GnRH agonist trigger.
PubMed 文献 · Reprod Biomed Online · 2022-12-02

回顾性队列研究纳入两个大型医疗中心2019至2021年接受GnRH激动剂扳机的患者,比较极高雌二醇组与正常范围雌二醇组。结果显示两组主要并发症和住院率无显著差异,但极高雌二醇组因腹痛等不适寻求医疗帮助的比例更高。作者认为极高雌二醇水平可能安全,但需更大规模研究确认。

要点

  • 极高雌二醇组与正常雌二醇组主要并发症率及住院率无显著差异。
  • 极高雌二醇组因腹痛等不适寻求医疗帮助的比例显著高于对照组。
  • 作者认为极高雌二醇水平可能安全,但需更大规模研究确认。

核心结论

  • 极高雌二醇水平未增加血栓栓塞事件、主要并发症或住院率,因此可能被认为是安全的。
  • 患者可被告知可能出现更高比例的不适,主要为腹痛。
  • 需更大规模研究确认结果。

研究设计与样本

  • 回顾性队列研究,纳入两个大型医疗中心2019至2021年治疗的患者。
  • 研究组为扳机日或前一日雌二醇极高者(扳机日≥20,000 pmol/l或前一日≥15,000 pmol/l),对照组为雌二醇正常范围(3000-12000 pmol/l)且接受GnRH激动剂扳机者。
  • 通过问卷调查取卵相关主诉和医疗 care,并查阅病历,比较主要并发症率和医疗求助需求。

主要发现

  • 研究组与对照组平均年龄分别为33.01 ± 5.14岁与34.57 ± 4.52岁(P < 0.001)。
  • 研究组与对照组平均峰值雌二醇分别为26645.34 ± 8592.57 pmol/l与7229.75 ± 2329.20 pmol/l(P < 0.001)。
  • 研究组与对照组平均获卵数分别为27.55 ± 13.46与11.67 ± 5.76(P < 0.001)。
  • 主要并发症率研究组3例(1.25%)与对照组1例(0.48%)相似(P = 0.62),住院率研究组3例(1.25%)与对照组2例(0.96%)相似(P = 1.0)。
  • 取卵后寻求医疗 care者研究组36例(15.1%)与对照组11例(5.3%),多因腹痛,无需进一步检查或住院(P < 0.001)。

临床怎么用

  • 原文结论认为极高雌二醇水平可能安全,患者可被告知可能出现更高比例的不适,主要为腹痛。
  • 原文未据此给出其他临床推荐。

局限性

  • 原文结论指出需更大规模研究确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Are IVF treatments with extremely high peak oestradiol levels and gonadotrophin releasing hormone (GnRH) agonist trigger associated with higher complication rates? DESIGN: A retrospective cohort study including patients from two large medical centres treated between 2019 and 2021. A study group with extremely high peak oestradiol levels (≥20,000 pmol/l on the day of ovarian stimulation, or ≥15,000 pmol/l on the previous day) and a control group with normal range oestradiol levels (3000-12000 pmol/l) that received GnRH agonist triggering. Patients were surveyed about complaints and medical care related to ovum retrieval and medical files were reviewed. Major complication rates and the need for medical assistance were compared. RESULTS: Several differences between the study and control group were observed because of the study design: mean age was 33.01 ± 5.14 versus 34.57 ± 4.52 (P < 0.001), mean peak oestradiol levels was 26645.34 ± 8592.57 pmol/l versus 7229.75 ± 2329.20 pmol/l (P < 0.001), and mean number of oocytes were 27.55 ± 13.46 versus 11.67 ± 5.76 (P < 0.001) for the study and control group, respectively. Major complications and hospitalization rates were similar between the study and control groups (three [1.25%] versus one [0.48%]; P = 0.62 and three [1.25%] versus two [0.96%]; P = 1.0, respectively). Thirty-six patients (15.1%) in the study group and 11 (5.3%) in the control group sought medical care after retrieval, mostly due to abdominal pain, without the need for further workup or hospitalization (P < 0.001). CONCLUSIONS: Extremely high oestradiol levels were not associated with thromboembolic events, higher major complication or hospitalization rates, and therefore may be considered safe. Nevertheless, patients may be informed of possible higher rates of discomfort, mostly abdominal pain. Larger studies are warranted to confirm our results.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Youngster M, Kedem A, Avraham S, et al. Treatment safety of ART cycles with extremely high oestradiol concentrations using GnRH agonist trigger. Reprod Biomed Online. 2022. PMID: 36566147. doi:10.1016/j.rbmo.2022.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。